B cells from CLL patients have higher cell surface levels of CD74 than do normal B cells, and it was shown that the activation of CD74 by MIF in CLL cells activates NF-κB and induces secretion of IL-8, which promotes cell survival and tumor progression [11,13]. This evidence concerns the gene MIF and B-cell chronic lymphocytic leukemia.